Article info
PDFCOVID-19
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
- Correspondence to Dr Hein M Tun, HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; heinmtun{at}hku.hk; Professor Francis KL Chan, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; fklchan{at}cuhk.edu.hk
Citation
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
Publication history
- Received November 13, 2021
- Accepted January 16, 2022
- First published February 9, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (31 May 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.